Production (Stage)
Lisata Therapeutics, Inc.
LSTA
$2.69
$0.041.51%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 1.00M | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 1.00M | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | 1.00M | -- | -- | -- |
| SG&A Expenses | 3.25M | 3.00M | 2.79M | 2.92M | 3.36M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.85M | 5.95M | 5.34M | 5.52M | 6.60M |
| Operating Income | -5.85M | -4.95M | -5.34M | -5.52M | -6.60M |
| Income Before Tax | -5.69M | -4.61M | -4.93M | -5.04M | -6.20M |
| Income Tax Expenses | -962.00K | 0.00 | -- | -- | -798.00K |
| Earnings from Continuing Operations | -4.72M | -4.61M | -4.93M | -5.04M | -5.40M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.72M | -4.61M | -4.93M | -5.04M | -5.40M |
| EBIT | -5.85M | -4.95M | -5.34M | -5.52M | -6.60M |
| EBITDA | -5.80M | -4.91M | -5.29M | -5.48M | -6.56M |
| EPS Basic | -0.55 | -0.55 | -0.59 | -0.61 | -0.65 |
| Normalized Basic EPS | -0.41 | -0.36 | -0.37 | -0.38 | -0.46 |
| EPS Diluted | -0.55 | -0.55 | -0.59 | -0.61 | -0.65 |
| Normalized Diluted EPS | -0.41 | -0.36 | -0.37 | -0.38 | -0.46 |
| Average Basic Shares Outstanding | 8.60M | 8.40M | 8.32M | 8.31M | 8.29M |
| Average Diluted Shares Outstanding | 8.60M | 8.40M | 8.32M | 8.31M | 8.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |